STIM:NASDAQ
Neuronetics Inc
$2.13
0.00%
(0.00) 1D
$2.13
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$2.13
High
$2.14
Low
$2.10
Mkt. cap
162.30M
Avg. vol.
1.15M
Volume
261.40K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$2.13
High
$2.14
Low
$2.10
Mkt. cap
162.30M
Avg. vol.
1.15M
Volume
261.40K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
The Business Journals
·
26 minutes ago
Axe Compute rings Nasdaq bell after pivoting from biotech to AI tokens
Stock Titan
·
7 minutes ago
A CEO's stock award could represent up to 289,855 shares if maximum performance is achieved.
CNBC
·
1 hour ago
Citi's Scott Chronert on getting the S&P 500 to 8,100: We need both parts of the market performing
Seeking Alpha
·
1 hour ago
Yes, The Technology Sector Will Lead S&P Profit Growth (Again)
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com